Document is current
Any future updates will be listed below
-
Authors
Liu, Shuying
Xie, Shelly M.
Liu, Wenbin
Gagea, Mihai
Hanker, Ariella B.
Nguyen, Nguyen
Singareeka Raghavendra, Akshara
Yang-Kolodji, Gloria
Chu, Fuliang
Neelapu, Sattva S.
Marchese, Adriano
Hanash, Samir
Zimmermann, Johann
Arteaga, Carlos L.
Tripathy, Debasish
-
Funding
Funding for this research was provided by:
Spexis Ltd
Victor and Anna Mae Beghini Charitable Foundation
A. Ray Weeks, Jr. Foundation
The National Cancer Institute through MD Anderson Cancer Center Support Grant (P30CA016672)
- License Information
-
More Information
Article History
Received: 17 December 2022
Accepted: 25 May 2023
First Online: 6 June 2023
Declarations
:
: All animal experiments were performed according to a UT MD Anderson Cancer Center Animal Care and Use Committee (IACUC) approved protocol, #00001044. Human samples were obtained under protocol approved by the institutional review board at The University of Texas MD Anderson Cancer Center. The Institutional Review Board of MD Anderson approved the laboratory study # 2020-0732.
: All authors have read the manuscript and agree to publish.
: JZ is an employee and shareholder of Spexis Ltd. Other authors declare no competing interests.
